chr13-99970413-TGGC-T
Position:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP3BP6_Very_StrongBA1
The NM_033132.5(ZIC5):βc.1188_1190delβ(p.Pro400del) variant causes a inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.202 in 1,099,906 control chromosomes in the GnomAD database, including 26,305 homozygotes. Variant has been reported in ClinVar as Benign (β β ).
Frequency
Genomes: π 0.37 ( 10159 hom., cov: 0)
Exomes π: 0.18 ( 16146 hom. )
Consequence
ZIC5
NM_033132.5 inframe_deletion
NM_033132.5 inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 2.56
Genes affected
ZIC5 (HGNC:20322): (Zic family member 5) This gene encodes a member of the ZIC family of C2H2-type zinc finger proteins. The encoded protein may act as a transcriptional repressor. Studies in mouse and Xenopus support a role for this gene in neural crest development. Elevated expression of this gene has been observed in various human cancers and may contribute to cancer progression. This gene is closely linked to a related family member on chromosome 13. [provided by RefSeq, Mar 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP3
Nonframeshift variant in repetitive region in NM_033132.5
BP6
Variant 13-99970413-TGGC-T is Benign according to our data. Variant chr13-99970413-TGGC-T is described in ClinVar as [Benign]. Clinvar id is 403621.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-99970413-TGGC-T is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.659 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZIC5 | NM_033132.5 | c.1188_1190del | p.Pro400del | inframe_deletion | 1/2 | ENST00000267294.5 | NP_149123.3 | |
ZIC5 | NR_146224.1 | n.1494_1496del | non_coding_transcript_exon_variant | 1/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZIC5 | ENST00000267294.5 | c.1188_1190del | p.Pro400del | inframe_deletion | 1/2 | 1 | NM_033132.5 | ENSP00000267294 | P1 |
Frequencies
GnomAD3 genomes AF: 0.372 AC: 45311AN: 121798Hom.: 10139 Cov.: 0
GnomAD3 genomes
AF:
AC:
45311
AN:
121798
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0131 AC: 796AN: 60812Hom.: 107 AF XY: 0.0114 AC XY: 424AN XY: 37140
GnomAD3 exomes
AF:
AC:
796
AN:
60812
Hom.:
AF XY:
AC XY:
424
AN XY:
37140
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.180 AC: 176352AN: 978006Hom.: 16146 AF XY: 0.177 AC XY: 82953AN XY: 469078
GnomAD4 exome
AF:
AC:
176352
AN:
978006
Hom.:
AF XY:
AC XY:
82953
AN XY:
469078
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.372 AC: 45384AN: 121900Hom.: 10159 Cov.: 0 AF XY: 0.371 AC XY: 22088AN XY: 59580
GnomAD4 genome
AF:
AC:
45384
AN:
121900
Hom.:
Cov.:
0
AF XY:
AC XY:
22088
AN XY:
59580
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at